PRINTER'S NO.  92

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

SENATE BILL

 

No.

76

Session of

2009

  

  

INTRODUCED BY GREENLEAF, FONTANA, WILLIAMS, ERICKSON, STOUT, MUSTO, FOLMER, BRUBAKER, ALLOWAY, M. WHITE, FERLO, COSTA, EARLL, WAUGH, O'PAKE, LEACH, WONDERLING AND STACK, JANUARY 30, 2009

  

  

REFERRED TO CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, JANUARY 30, 2009  

  

  

  

AN ACT

  

1

Amending the act of September 27, 1961 (P.L.1700, No.699),

2

entitled "An act relating to the regulation of the practice

3

of pharmacy, including the sales, use and distribution of

4

drugs and devices at retail; and amending, revising,

5

consolidating and repealing certain laws relating thereto,"

6

further providing for refusal to grant and revocation and

7

suspension of licenses; and providing for the donation of

8

unused prescription drugs.

9

The General Assembly of the Commonwealth of Pennsylvania

10

hereby enacts as follows:

11

Section 1.  Section 5(a)(9) of the act of September 27, 1961

12

(P.L.1700, No.699), known as the Pharmacy Act, amended December

13

20, 1985 (P.L.433, No.111), is amended to read:

14

Section 5.  Refusal to Grant, Revocation and Suspension.--(a)

15

The board shall have the power to refuse, revoke or suspend the

16

license of any pharmacist upon proof satisfactory to it that the

17

pharmacist:

18

* * *

19

(9)  Is guilty of grossly unprofessional conduct. The

 


1

following acts on the part of a pharmacist are hereby declared

2

to constitute grossly unprofessional conduct of a pharmacist:

3

(i)  Willfully deceiving or attempting to deceive the State

4

Board of Pharmacy or its agents with respect to any material

5

matter under investigation by the board;

6

(ii)  Advertising of prices for drugs and pharmaceutical

7

services to the public which does not conform to Federal laws or

8

regulations;

9

(iii)  The public assertion or implication of professional

10

superiority in the practice of pharmacy;

11

(iv)  The engaging by any means in untrue, false, misleading

12

or deceptive advertising of drugs or devices;

13

(v)  Paying rebates to physicians or any other persons, or

14

the entering into any agreement with a medical practitioner or

15

any other person for the payment or acceptance of compensation

16

in any form for the recommending of the professional services of

17

either party;

18

(vi)  The entering into of any agreement with a licensed

19

medical practitioner for the compounding or dispensing of secret

20

formula (coded), prescriptions;

21

(vii)  The misbranding or adulteration of any drug or device

22

and the sale, distribution or dispensing of any misbranded or

23

adulterated drug or device as defined in the act of April 14,

24

1972 (P.L.233, No.64), known as "The Controlled Substance, Drug,

25

Device and Cosmetic Act";

26

(viii)  Engaging in the sale or purchase of drugs or devices

27

whose package bears the inscription "sample" or "not for

28

resale;"

29

(ix)  Displaying or permitting the display of his certificate

30

of licensure and biennial registration document in a pharmacy of

- 2 -

 


1

which he is not the proprietor or in which he is not employed;

2

(x)  Any holder of a biennial pocket registration card who

3

fails to have the card available for inspection by an authorized

4

agent when he is practicing;

5

(xi)  The acceptance back and redistribution of any unused

6

drug, or a part thereof, except as authorized under section 9.3

7

of this act, after it has left the premises of any pharmacy,

8

whether issued by mistake or otherwise, unless it is in the

9

original sealed container with the name, lot number and

10

expiration date on the original intact manufacturer's label. The

11

pharmacy shall maintain records of all such returns, and a full

12

refund shall be given to the original purchaser, including a

13

third-party payor;

14

(xii)  To accept employment as a pharmacist, or share or

15

receive compensation in any form arising out of, or incidental

16

to, his professional activities from any medical practitioner or

17

any other person or corporation in which one or more medical

18

practitioners have a proprietary or beneficial interest

19

sufficient to permit them to exercise supervision or control

20

over the pharmacist in his professional responsibilities and

21

duties;

22

(xiii)  To accept employment as a pharmacist, or share or

23

receive compensation in any form arising out of, or incidental

24

to, his professional activities from any person who orders said

25

pharmacist, directly or indirectly, to engage in any aspect of

26

the practice of pharmacy in contravention of any provision of

27

this act.

28

* * *

29

Section 2.  The act is amended by adding a section to read:

30

Section 9.3.  Donation of Unused Prescription Drugs.--(a)  

- 3 -

 


1

The Department of Health, the board and the Health Care Cost

2

Containment Council shall jointly develop and implement a pilot

3

program consistent with public health and safety through which

4

unused prescription drugs, other than drugs that are controlled

5

dangerous substances, may be transferred from nursing facilities

6

to pharmacies operated by the Commonwealth for the purpose of

7

distributing the prescription drugs to residents who are

8

medically indigent.

9

(b)  The Department of Health, the board, the Health Care

10

Cost Containment Council, the State Board of Medicine and the

11

State Board of Osteopathic Medicine shall review and evaluate

12

the program no later than eighteen months after its

13

implementation and shall submit a report and any recommendations

14

to the Governor, the President pro tempore of the Senate, the

15

Speaker of the House of Representatives and the chairmen of the

16

appropriate legislative committees.

17

(c)  The Department of Health, the board and the Health Care

18

Cost Containment Council shall promulgate rules and establish

19

procedures necessary to implement the program established by

20

this section. The rules and procedures shall provide:

21

(1)  For a formulary for the medications to be distributed

22

pursuant to the program.

23

(2)  For the protection of the privacy of the individual for

24

whom the medication was originally prescribed.

25

(3)  For the integrity and safe storage and safe transfer of

26

the medication, which may include, but shall not be limited to,

27

limiting the drugs made available through the program to those

28

that were originally dispensed by unit dose or an individually

29

sealed dose or which remain in intact packaging.

30

(4)  For the tracking of and accountability for the

- 4 -

 


1

medications.

2

(5)  For other matters necessary for the implementation of

3

the program.

4

(d)  In accordance with the rules and procedures of a program

5

established pursuant to this section, the resident of a nursing

6

facility or the representative or guardian of a resident may

7

donate unused prescription drugs, other than prescription drugs

8

that are controlled dangerous substances, for dispensation to

9

residents who are medically indigent.

10

(e)  No physician, pharmacist and other health care

11

professional shall be subject to liability for participation in

12

the program established by this section when acting within the

13

scope of practice of his license and in good faith compliance

14

with the rules promulgated pursuant to this section.

15

(f)  For purposes of this section, "persons who are medically

16

indigent" means persons who have no health insurance or who

17

otherwise lack reasonable means to purchase prescribed

18

medications.

19

Section 3.  This act shall take effect in 60 days.

- 5 -